Transcenta Holding
Chemicals & Related Products · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3 Independence Way Ste 114, Princeton, N...Phone Number
+86 57128279502Website
www.transcenta.comRevenue
$28.2 MillionIndustry
About Transcenta Holding
Transcenta Holding is a global fully integrated biotherapeutics company that specializes in developing innovative biologics, including antibodies targeting Claudin 18.2. The company employs cutting-edge technology to create differentiated and affordable treatments for patients, with a focus on oncology. With a robust pipeline of products, including Osemitamab (TST001), TST002, and TST003, Transcenta is committed to advancing clinical development and manufacturing processes. Their strategic partnerships with leading pharmaceutical companies enhance their capabilities in research and development, ensuring a strong presence in the biopharmaceutical industry.Explore more
SIC Code 28,283NAICS Code 32,325Show moreTranscenta Holding Org Chart
Compare Similar Companies to Transcenta Holding
Compare insights from companies similar to Transcenta Holding, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Transcenta Holding Tech Stack
A closer look at the technologies used by Transcenta Holding
See more technologies
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Transcenta Holding
Sign Up For FreeTo access detailed company insights
Transcenta Holding is a global fully integrated biotherapeutics company that specializes in developing innovative biologics, including antibodies targeting Claudin 18.2. The company employs cutting-edge technology to create differentiated and affordable treatments for patients, with a focus on oncology. With a robust pipeline of products, including... Read More